Eigen Therapeutics
No two cancers are the same. Let's treat it that way.
Redwood City, United States · Founded 2021 · $7.0M raised
- Headquarters
- Redwood City, California
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- eigentx.com
- Total Funding
- $7.0M
- Last Round
- $7.0M SeedDec 2022
- Rounds
- 1
About
Eigen Therapeutics is a biotechnology company developing co-therapies that improve the efficacy of targeted cancer treatments by modulating tumor cell-surface targets. Its AI-driven discovery platform combines high-throughput biology, laboratory robotics, and machine learning to identify combination therapies for cancers with heterogeneous target expression. The approach expands patient eligibility for existing targeted therapies while reducing side effects.
Summary
Eigen Therapeutics is a Biotech company based in Redwood City, United States, founded in 2021. It has raised $7.0M in total across 1 round, most recently a $7.0M Seed round in Dec 2022. Investors include First Round Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2022
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Global contract research organization providing comprehensive drug development and laboratory ser...